CVA Family Office’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-50
Closed -$7K – 1021
2022
Q3
$7K Hold
50
– – ﹤0.01% 687
2022
Q2
$9K Buy
50
+35
+233% +$5.04K ﹤0.01% 667
2022
Q1
$2K Sell
15
-15
-50% -$2.03K ﹤0.01% 894
2021
Q4
$5K Buy
+30
New +$5.02K ﹤0.01% 763
2021
Q3
– Sell
-100
Closed -$16K – 931
2021
Q2
$16K Buy
100
+95
+1,900% +$14.1K ﹤0.01% 576
2021
Q1
$1K Buy
+5
New +$806 ﹤0.01% 769

Other funds holding SGEN

CVA Family Office's SGEN Position: Q4 2022 in Review

CVA Family Office sold out of Seagen Inc. Common Stock (SGEN) in Q4 2022, closing a stake of 50 shares — an estimated $7K sold.

CVA Family Office first reported a position in SGEN in Q1 2021 and held it in 6 quarters. The position peaked at $16K in Q2 2021. 537 funds tracked by Wall St. Rank hold SGEN as of Q4 2022.

  • CVA Family Office reported no remaining Seagen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • CVA Family Office sold 50 Seagen Inc. Common Stock shares in Q4 2022, an estimated $7K.
  • CVA Family Office first reported a position in Seagen Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • CVA Family Office's Seagen Inc. Common Stock position peaked at $16K in Q2 2021.
  • 537 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2022.

Based on CVA Family Office's 13F filing for Q4 2022, filed 22 Feb 2023.